SMITH, SALLEY & ASSOCIATES – Protalix BioTherapeutics, Inc. Transaction History
SMITH, SALLEY & ASSOCIATES portfolio value:
$13,000
portfolio value
SMITH, SALLEY & ASSOCIATES quarter portfolio value change:
-4.46%
quarter
Protalix BioTherapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 0 | $1.04 | 12.04K | |
| Q2 2022 | share | 0.00% | 0 shares | 0 | $1.09 | 12.04K | |
| Q1 2022 | share | Increase | 0.00% | 12.04K shares | 13K | $1.06 | 12.04K |